Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8869 |
High Similarity |
NPD8434 |
Phase 2 |
0.8447 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.8447 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.8242 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7964 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7931 |
Intermediate Similarity |
NPD6764 |
Approved |
0.7931 |
Intermediate Similarity |
NPD6765 |
Approved |
0.7931 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7927 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7925 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7853 |
Intermediate Similarity |
NPD920 |
Approved |
0.7849 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7831 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7798 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7765 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7753 |
Intermediate Similarity |
NPD6785 |
Approved |
0.7753 |
Intermediate Similarity |
NPD6784 |
Approved |
0.7753 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7751 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7738 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7701 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.768 |
Intermediate Similarity |
NPD8404 |
Phase 2 |
0.7679 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7674 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7669 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7665 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7657 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7651 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7637 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7633 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7625 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7622 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7616 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7605 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7602 |
Intermediate Similarity |
NPD919 |
Approved |
0.7588 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7544 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7542 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7542 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7531 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7529 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7515 |
Intermediate Similarity |
NPD37 |
Approved |
0.7515 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7515 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7515 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7515 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7514 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7486 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7485 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7485 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7471 |
Intermediate Similarity |
NPD2801 |
Approved |
0.747 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7453 |
Intermediate Similarity |
NPD2796 |
Approved |
0.744 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7425 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7425 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7423 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7418 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7416 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7414 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7414 |
Intermediate Similarity |
NPD1247 |
Approved |
0.741 |
Intermediate Similarity |
NPD5401 |
Approved |
0.741 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.741 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7391 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7386 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7384 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7374 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7362 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.736 |
Intermediate Similarity |
NPD7054 |
Approved |
0.736 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7346 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7346 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7346 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7337 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.733 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.733 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7318 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7317 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7308 |
Intermediate Similarity |
NPD8407 |
Phase 2 |
0.7303 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.7303 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7303 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7301 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7293 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7289 |
Intermediate Similarity |
NPD7236 |
Approved |
0.7273 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7273 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7256 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD1511 |
Approved |
0.724 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7238 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7238 |
Intermediate Similarity |
NPD8368 |
Discontinued |
0.7235 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7215 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7207 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7205 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7198 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7195 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7182 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7178 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7178 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7178 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7176 |
Intermediate Similarity |
NPD7239 |
Suspended |
0.716 |
Intermediate Similarity |
NPD1512 |
Approved |
0.715 |
Intermediate Similarity |
NPD7497 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7134 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7126 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7125 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7117 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7099 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7083 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7083 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7083 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7083 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7083 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7083 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7083 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7081 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.7072 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7069 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7066 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7066 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7066 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7066 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7059 |
Intermediate Similarity |
NPD8435 |
Approved |
0.7059 |
Intermediate Similarity |
NPD8361 |
Approved |
0.7059 |
Intermediate Similarity |
NPD8360 |
Approved |
0.7055 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7055 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7051 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7037 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7024 |
Intermediate Similarity |
NPD2309 |
Approved |
0.702 |
Intermediate Similarity |
NPD7874 |
Approved |
0.702 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7019 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7019 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7019 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.701 |
Intermediate Similarity |
NPD7907 |
Approved |
0.6995 |
Remote Similarity |
NPD5953 |
Discontinued |
0.6994 |
Remote Similarity |
NPD230 |
Phase 1 |
0.6988 |
Remote Similarity |
NPD5763 |
Approved |
0.6988 |
Remote Similarity |
NPD5762 |
Approved |
0.6983 |
Remote Similarity |
NPD5711 |
Approved |
0.6983 |
Remote Similarity |
NPD5710 |
Approved |
0.6975 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6974 |
Remote Similarity |
NPD7697 |
Approved |
0.6974 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6974 |
Remote Similarity |
NPD7698 |
Approved |
0.697 |
Remote Similarity |
NPD8151 |
Discontinued |
0.697 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6964 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.6957 |
Remote Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.6943 |
Remote Similarity |
NPD8285 |
Discontinued |
0.6939 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6939 |
Remote Similarity |
NPD8320 |
Phase 1 |
0.6939 |
Remote Similarity |
NPD8319 |
Approved |
0.6939 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6933 |
Remote Similarity |
NPD4140 |
Approved |
0.6927 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6919 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6918 |
Remote Similarity |
NPD2797 |
Approved |
0.6912 |
Remote Similarity |
NPD4111 |
Phase 1 |
0.6912 |
Remote Similarity |
NPD4665 |
Approved |
0.6906 |
Remote Similarity |
NPD2403 |
Approved |
0.69 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.69 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.69 |
Remote Similarity |
NPD7801 |
Approved |
0.689 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.689 |
Remote Similarity |
NPD1933 |
Approved |
0.6889 |
Remote Similarity |
NPD6808 |
Phase 2 |
0.6886 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6886 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6886 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6886 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6886 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6878 |
Remote Similarity |
NPD4287 |
Approved |
0.6875
|
Remote Similarity |
NPD2798 |
Approved |